Enterprise Value
492.7M
Cash
329.4M
Avg Qtr Burn
-9.02M
Short % of Float
2.51%
Insider Ownership
8.45%
Institutional Own.
87.37%
Qtr Updated
03/31/23
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|